Last edited by Akilkis
Thursday, July 30, 2020 | History

7 edition of Peripheral receptor targets for analgesia found in the catalog.

Peripheral receptor targets for analgesia

novel approaches to pain treatment

  • 386 Want to read
  • 18 Currently reading

Published by John Wiley & Sons in Hoboken, N.J .
Written in English

    Subjects:
  • Nociceptors ,
  • Nerves, Peripheral,
  • Analgesia,
  • Analgesics,
  • Pain,
  • Pain -- drug therapy,
  • Analgesics -- therapeutic use,
  • Drug Delivery Systems,
  • Pain -- physiopathology,
  • Receptors, Drug -- physiology

  • Edition Notes

    Includes index.

    Statementedited by Brian E. Cairns.
    ContributionsCairns, Brian E.
    Classifications
    LC ClassificationsQP451.4 .P47 2009
    The Physical Object
    Paginationp. ;
    ID Numbers
    Open LibraryOL23186281M
    ISBN 109780470251317
    LC Control Number2009009731

    Learn opioid receptors with free interactive flashcards. Choose from different sets of opioid receptors flashcards on Quizlet. booktitle = "Peripheral Receptor Targets for Analgesia", publisher = "Wiley", Cairns, BE , Glutamate receptors. i BE Cairns (red.), Peripheral Receptor Targets for Analgesia: Novel Approaches to Pain Management.

    This appears to largely be a result of actions of opioid drugs at targets other than the three classic opioid receptors, including the nociceptin receptor, sigma receptor and Toll-like receptor 4, and can be counteracted in animal models by antagonists at these targets such as J,, BD or (+)-naloxone code: N02A. booktitle = "Peripheral Receptor Targets for Analgesia", publisher = "Wiley", Cairns, BE & Prateepavanich, P , Role of peripheral mechanisms in spinal pain conditions. i BE Cairns (red.), Peripheral Receptor Targets for Analgesia: Novel Approaches to Pain Management.

    Morphine peripheral analgesia depends on activation of the PI3Kγ/AKT/nNOS/NO/KATP signaling pathway Morphine peripheral analgesia was discovered by its direct and that opioid-receptor activation in vitro was coupled to ade-nylyl-cyclase inhibition (3), . One ideal target that has had a lot of attention is the kappa opioid receptor agonist. It has been shown that the kappa opioid receptor plays a role in analgesia, however, it comes with its own adverse effects that may limit its potential. To limit these possible adverse effects, researchers began to target peripheral kappa opioid receptors.


Share this book
You might also like
Report.

Report.

East India (Disturbances in the Punjab, etc.).

East India (Disturbances in the Punjab, etc.).

Habitat requirements of juvenile Colorado River squawfish

Habitat requirements of juvenile Colorado River squawfish

Financing municipal government in Denver.

Financing municipal government in Denver.

Economic and environmental costs of electricity and natural gas in B.C. lower mainland

Economic and environmental costs of electricity and natural gas in B.C. lower mainland

Americas history

Americas history

FERRELLGAS PARTNERS, L.P.

FERRELLGAS PARTNERS, L.P.

6th Guards Tank Brigade

6th Guards Tank Brigade

Ice-bound on Kolguev

Ice-bound on Kolguev

university handbook

university handbook

way of wyrd

way of wyrd

Flower arrangements

Flower arrangements

Jacob Angstadt, his diaber [i.e. diaper] book

Jacob Angstadt, his diaber [i.e. diaper] book

Peripheral receptor targets for analgesia Download PDF EPUB FB2

A comprehensive review of peripheral pain mechanisms, Peripheral Receptor Targets for Analgesia: Novel Approaches to Pain Management provides a unique resource that brings together a body of knowledge that was previously widely dispersed.

As such, it gives readers a framework for further basic and clinical studies on potential Peripheral receptor targets for analgesia book targets. A comprehensive review of peripheral pain mechanisms, Peripheral Receptor Targets for Analgesia: Novel Approaches to Pain Management provides a unique resource that brings together a body of knowledge that was previously widely dispersed.

As such, it gives readers a framework for further basic and clinical studies on potential receptor targets Cited by: Adrenergic receptors. Sensory effects by cutaneous administration of endogenous adrenergic ligands. Plasticity in peripheral adrenergic systems following injury or inflammation.

Pathophysiological changes in peripheral mechanisms contributing to adrenergic pain modulation. Findings supporting a pain facilitatory role of peripheral α2. Get this from a library. Peripheral receptor targets for analgesia: novel approaches to pain treatment. [Brian E Cairns;] -- While considerable advances have been made on pharmacotherapies for many chronic disease states, options available to treat chronic pain have remained relatively unchanged for decades.

However. Get this from a library. Peripheral receptor targets for analgesia: novel approaches to pain treatment. [Brian E Cairns;] -- Peripheral Receptor Targets for Analgesia.

Novel Approaches to Pain Management. Edited by. Brian E. Cairns. A unique reference on peripheral pain receptor mechanisms. While considerable advances have. Major recent findings in peripheral opioid analgesia include the relative lack of tolerance under inflammatory conditions, tetrapeptides as novel peripherally restricted compounds, the potent anti-inflammatory activity of μ and κ agonists and the identification of selectins as important molecules governing the homing of opioid cells to injured by: Our results indicate that NFEPP exerts peripheral opioid receptor-mediated analgesia exclusively in damaged tissue in models of neuropathic and abdominal is an open-access article.

Cummins, Theodore R. / Voltage-Gated Sodium Channels in Peripheral Nociceptive Neurons as Targets for the Treatment of Pain. Peripheral Receptor Targets for Analgesia: Novel Approaches to Pain Management.

John Wiley and Sons, pp. Author: Theodore R. Cummins. Peripheral mechanisms of opioid analgesia have gained recognition in the clinical setting. Opioid receptors have been demonstrated on peripheral terminals of sensory nerves in human synovia (Mousa et al., b; Stein et al., ), dermal and epidermal nerve fibers (Ständer et al., ) and dental pulp (Jaber et al., ).Cited by: receptors, peripheral (or peripherally restricted) opioid agonists, and peripheral mu- kappa- and delta-opioid receptor agonists, followed by full-text access and further by: 7 Morphine may produce peripheral analgesia by inhibiting adenylatecyclase activity at the nociceptors.

Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (M), or click on a Cited by: Nonsteroidal anti-inflammatory drugs produce peripheral analgesia but have significant toxicity.

GABA B receptors represent peripheral targets for analgesia but selective GABA B agonists like baclofen cross the blood–brain barrier. Recently, we found that the CNS-impermeant amino acid, isovaline, produces analgesia without apparent CNS by: Activation of cannabinoid receptors using systemic treatments produces analgesia in a variety of experimental pain models, but these effects are hindered by sedation and motor impairment mediated by receptors in the central nervous system.

Targeting the endocannabinoid system in the periphery can bypass these unwanted side effects while still producing analgesia in both Author: Megan L. Uhelski, Iryna Khasabova, Donald A. Simone. PHARMACOLOGY – Vol. II - Pain Pharmacology and Analgesia - Maree T. Smith, Samantha M. South ©Encyclopedia of Life Support Systems (EOLSS) Non-Neuronal Cells in the DRG and the CNS Satellite Glia Cells in the DRG Activated Microglia and Astrocytes in the CNS 4.

Endogenous pain relief system Processing of low-intensity stimuliFile Size: KB. The NMDA receptor has long been associated with central sensitization changes that lead to chronic neuropathic pain.

1,2,6,18,20, Until recently, peripheral actions were not felt to be an active contributor to sensitization processes. ain or has peripheral sites of antinociceptive action has not been determined. Thus, we studied central (IT) and peripheral (intraarticular; IA) neostigmine in a rat inflamed knee joint model.

Inhibition of thermal and mechanical hyperalgesia was assessed over 28 h using a modified Hargreaves box and von Frey hairs, respectively. IT neostigmine resulted in a dose-dependent. In contrast to its effects on nociception, σ 1-receptor inhibition did not alter fentanyl- or loperamide-induced constipation, a peripherally mediated nonanalgesic opioid effect.

Therefore, σ 1-receptor inhibition may be used as a systemic or local adjuvant to enhance peripheral μ -opioid analgesia without affecting opioid-induced by:   sigma-1 receptors; inflammatory pain; endogenous opioid peptides; immune cells; There is a need for new analgesics with innovative mechanisms of action ().The sigma-1 receptor acts as a ligand-operated chaperone, which modifies the function of several receptors and channels important in neurotransmission (), and has been the focus of intense preclinical Cited by: 9.

In Analgesia: Methods and Protocols, experts in the field present thorough coverage of molecular analgesia research methods from target discovery through target validation and clinical testing to tolerance and dependence, with extensive chapters on emerging receptor classes as targets for analgesic drugs and innovative analgesic strategies.

Opioid receptors are a group of inhibitory G protein-coupled receptors with opioids as ligands. The endogenous opioids are dynorphins, enkephalins, endorphins, endomorphins and opioid receptors are ~40% identical to somatostatin receptors (SSTRs). Opioid receptors are distributed widely in the brain, in the spinal cord, on peripheral neurons, and digestive tract.

Peripheral sensitization indicates increased responsiveness and reduced threshold of nociceptive neurons in the periphery to the stimulation, which usually occurs after peripheral tissue injury and inflammation. As an integral part of pain, peripheral sensitization and its mechanisms have received much attention, and numerous types of neurotransmitters and chemicals related to.

With neuropathic pain, the spinal cord suffers a loss of “inhibitory tone”—signaling by GABA, the nervous system’s main inhibitory transmitter. GABA receptors would seem an ideal target to dampen neuropathic hyperexcitability, but considerable efforts toward that aim have largely failed, mainly because GABA receptors are found throughout the nervous system.

Rowbotham MC, Arslanian A, Nothaft W, Duan WR, Best AE, Pritchett Y, et al. Efficacy and safety of the α4β2 neuronal nicotinic receptor agonist ABT in patients with diabetic peripheral neuropathic pain. Pain. ;(4)– by: 4.